Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.68 |
| ▸ | PPARG | P37231 | 5/20 | 0.61 |
| ▸ | PPARA | Q07869 | 5/20 | 0.61 |
| ▸ | TERT | O14746 | 3/20 | 0.61 |
| ▸ | PPARD | Q03181 | 3/20 | 0.61 |
| ▸ | TOP1 | P11387 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | FABP4 | P15090 | 2/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23116328 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23802594 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23116282 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23116356 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23116360 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23116355 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23116319 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23116283 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23116326 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL23116320 | 1.00 | PTPN1 (0.68) | PTPN1PPARGPPARATERTPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600917-B2 | Lubricating oil additive composition and lubricating oil composition | ENEOS CORPORATION (JP) | 2026-04-14 | — | — | US | disclosed |
| EP-4711450-A1 | ENZYME AGENT FOR CARBOXY GROUP GENERATION AND APPLICATION THEREOF | Amano Enzyme Inc. (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20260068915-A1 | Lipid Compositions and Methods Thereof | NAT UNIV SINGAPORE (SG) | 2026-03-12 | — | — | US | disclosed |
| EP-4704609-A1 | VERY LONG CHAIN FATTY ACIDS FOR USE IN MINERALIZATION | Epax Norway AS (NO) | 2026-03-11 | — | — | EP | disclosed |
| US-20260014109-A1 | VERY LONG CHAIN FATTY ACIDS FOR TREATMENT AND ALLEVIATION OF DISEASES | EPAX NORWAY AS (NO) | 2026-01-15 | — | — | US | disclosed |
| EP-4663765-A1 | PROCESSED UNSATURATED FATTY ACID-CONTAINING COMPOSITION PRODUCTION METHOD AND APPLICATION OF SAME | Amano Enzyme Inc. (JP) | 2025-12-17 | — | — | EP | disclosed |
| EP-4663766-A1 | METHOD FOR PRODUCING COMPOSITION CONTAINING PROCESSED FATTY ACID, AND USE FOR SAME | Amano Enzyme Inc. (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-20250354081-A1 | LUBRICATING OIL ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITION | ENEOS CORPORATION (JP) | 2025-11-20 | — | — | US | disclosed |
| US-20250340795-A1 | LUBRICATING OIL ADDITIVE COMPOSITION AND LUBRICATING OIL COMPOSITION | ENEOS CORPORATION (JP) | 2025-11-06 | — | — | US | disclosed |
| US-20250326982-A1 | LUBRICATING OIL COMPOSITION | ENEOS CORPORATION (JP) | 2025-10-23 | — | — | US | disclosed |
| CN-115279874-A | Grease composition | 出光兴产株式会社 | 2022-11-01 | — | — | CN | disclosed |
| EP-2962739-B1 | GOLF BALL | SUMITOMO RUBBER IND (JP) | 2022-09-28 | — | — | EP | disclosed |
| WO-2022197960-A1 | METHODS AND COMPOSITIONS FOR TREATING EYE DISEASES | JENIVISION INC. (US) | 2022-09-22 | — | — | WO | disclosed |
| US-20220233488-A1 | VERY LONG CHAIN FATTY ACIDS FOR TREATMENT AND ALLEVIATION OF DISEASES | EPAX NORWAY AS (NO) | 2022-07-28 | — | — | US | disclosed |
| US-20220177804-A1 | LUBRICATING OIL COMPOSITION | ENEOS CORPORATION (JP) | 2022-06-09 | — | — | US | disclosed |
| CN-114591777-A | Lubricating oil composition | 引能仕株式会社 | 2022-06-07 | — | — | CN | disclosed |
| US-11319369-B2 | Motor control function improving agent | KAO CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
| EP-3976020-A1 | VERY LONG CHAIN FATTY ACIDS FOR TREATMENT AND ALLEVIATION OF DISEASES | Epax Norway AS (NO) | 2022-04-06 | — | — | EP | disclosed |
| WO-2022054190-A1 | A RUBBER COMPOSITION | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2022-03-17 | — | — | WO | disclosed |
| US-20210086036-A1 | GOLF BALL | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2021-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600917-B2 | Lubricating oil additive composition and lubricating oil composition | PHOSPHO1, F12, C9 | PTPN1 4226/4885PPARG 1760/4885PPARA 697/4885 |
| US-20260068915-A1 | Lipid Compositions and Methods Thereof | MGLL, FASN, AUP1 | PTPN1 4807/4885PPARG 69/4885PPARA 241/4885 |
| US-20260014109-A1 | VERY LONG CHAIN FATTY ACIDS FOR TREATMENT AND ALLEVIATION OF DISEASES | ELOVL3, ELOVL1, ELOVL6 | PTPN1 4467/4885PPARG 179/4885PPARA 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.